trending Market Intelligence /marketintelligence/en/news-insights/trending/5snwry-lh3hcu-vlmaj0ra2 content esgSubNav
In This List

PAVmed closes $10.4M rights offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


PAVmed closes $10.4M rights offering

PAVmed Inc. raised $10.4 million in the closing of a previously announced oversubscribed rights offering.

The New York-based medical device company issued a total of 9 million units in the offering.

Each right allowed the holders to buy one unit at $1.15 apiece, with each unit consisting of 1 common share and 1 series Z warrant to buy 1 PAVmed common share at $1.60 per share.

PAVmed said the units were immediately split into their underlying securities. Furthermore, the common stock and warrants will be immediately tradable upon issuance.

Maxim Group LLC and Dawson James Securities Inc. acted as dealer-managers in the transaction.